LVTX
LAVA Therapeutics NV
Latest Form 4:Sale$1.0MbyCooperatieve Gilde Healthcare IV U.A. (10% Owner) · filed Oct 20, 2025
LAVA Therapeutics NV (LVTX) has 5 SEC Form 4 filings (7 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Nov 17, 2025.
The most active filer is 10% Owner Cooperatieve Gilde Healthcare IV U.A. with 3 filings. Insiders have net sold $4.2M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Stephen Allen Hurly
- Employees:34
- HQ:Utrecht, NL
- IPO:2021-03-26
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.2M
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
Cooperatieve Gilde Healthcare IV U.A.First filing | 10% Owner | Sale | 690,239 | $1.0M | Oct 20 | SEC ↗ |
Cooperatieve Gilde Healthcare IV U.A.First filing | 10% Owner | Sale | 1,181,131 | $1.7M | Oct 20 | SEC ↗ |
Cooperatieve Gilde Healthcare IV U.A.First filing | 10% Owner | Sale | 1,000,000 | $1.5M | Oct 20 | SEC ↗ |